124 related articles for article (PubMed ID: 38189137)
21. Nitrated fatty acids reverse pulmonary fibrosis by dedifferentiating myofibroblasts and promoting collagen uptake by alveolar macrophages.
Reddy AT; Lakshmi SP; Zhang Y; Reddy RC
FASEB J; 2014 Dec; 28(12):5299-310. PubMed ID: 25252739
[TBL] [Abstract][Full Text] [Related]
22. Alveolar epithelial cells in idiopathic pulmonary fibrosis display upregulation of TRAIL, DR4 and DR5 expression with simultaneous preferential over-expression of pro-apoptotic marker p53.
Akram KM; Lomas NJ; Forsyth NR; Spiteri MA
Int J Clin Exp Pathol; 2014; 7(2):552-64. PubMed ID: 24551275
[TBL] [Abstract][Full Text] [Related]
23. Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis.
Andersson CK; Andersson-Sjöland A; Mori M; Hallgren O; Pardo A; Eriksson L; Bjermer L; Löfdahl CG; Selman M; Westergren-Thorsson G; Erjefält JS
Respir Res; 2011 Oct; 12(1):139. PubMed ID: 22014187
[TBL] [Abstract][Full Text] [Related]
24. DROSHA-Dependent AIM2 Inflammasome Activation Contributes to Lung Inflammation during Idiopathic Pulmonary Fibrosis.
Cho SJ; Hong KS; Jeong JH; Lee M; Choi AMK; Stout-Delgado HW; Moon JS
Cells; 2019 Aug; 8(8):. PubMed ID: 31434287
[TBL] [Abstract][Full Text] [Related]
25. Myeloid Fbxw7 Prevents Pulmonary Fibrosis by Suppressing TGF-β Production.
He J; Du Y; Li G; Xiao P; Sun X; Song W; Lai L; Xia M; Zhang J; Wang Q
Front Immunol; 2021; 12():760138. PubMed ID: 35069531
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of TIM-3 in Macrophages Aggravates Pathogenesis of Pulmonary Fibrosis in Mice.
Wang Y; Kuai Q; Gao F; Wang Y; He M; Zhou H; Han G; Jiang X; Ren S; Yu Q
Am J Respir Cell Mol Biol; 2019 Dec; 61(6):727-736. PubMed ID: 31162951
[TBL] [Abstract][Full Text] [Related]
27. Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-β receptor I internalization and inhibiting transforming growth factor-β1 signaling.
Shi Y; Gochuico BR; Yu G; Tang X; Osorio JC; Fernandez IE; Risquez CF; Patel AS; Shi Y; Wathelet MG; Goodwin AJ; Haspel JA; Ryter SW; Billings EM; Kaminski N; Morse D; Rosas IO
Am J Respir Crit Care Med; 2013 Oct; 188(7):831-41. PubMed ID: 23924348
[TBL] [Abstract][Full Text] [Related]
28. Comparative study of transforming growth factor-β signalling and regulatory molecules in human and canine idiopathic pulmonary fibrosis.
Lilja-Maula L; Syrjä P; Laurila HP; Sutinen E; Rönty M; Koli K; Rajamäki MM; Myllärniemi M
J Comp Pathol; 2014 May; 150(4):399-407. PubMed ID: 24529509
[TBL] [Abstract][Full Text] [Related]
29. Myeloid- and Epithelial-derived Heparin-Binding Epidermal Growth Factor-like Growth Factor Promotes Pulmonary Fibrosis.
Hult EM; Gurczynski SJ; O'Dwyer DN; Zemans RL; Rasky A; Wang Y; Murray S; Crawford HC; Moore BB
Am J Respir Cell Mol Biol; 2022 Dec; 67(6):641-653. PubMed ID: 36036796
[TBL] [Abstract][Full Text] [Related]
30. Loss of epithelial Gq and G11 signaling inhibits TGFβ production but promotes IL-33-mediated macrophage polarization and emphysema.
John AE; Wilson MR; Habgood A; Porte J; Tatler AL; Stavrou A; Miele G; Jolly L; Knox AJ; Takata M; Offermanns S; Jenkins RG
Sci Signal; 2016 Oct; 9(451):ra104. PubMed ID: 27811142
[TBL] [Abstract][Full Text] [Related]
31. Inhibition and role of let-7d in idiopathic pulmonary fibrosis.
Pandit KV; Corcoran D; Yousef H; Yarlagadda M; Tzouvelekis A; Gibson KF; Konishi K; Yousem SA; Singh M; Handley D; Richards T; Selman M; Watkins SC; Pardo A; Ben-Yehudah A; Bouros D; Eickelberg O; Ray P; Benos PV; Kaminski N
Am J Respir Crit Care Med; 2010 Jul; 182(2):220-9. PubMed ID: 20395557
[TBL] [Abstract][Full Text] [Related]
32. A novel phosphodiesterase 4 inhibitor, AA6216, reduces macrophage activity and fibrosis in the lung.
Matsuhira T; Nishiyama O; Tabata Y; Kaji C; Kubota-Ishida N; Chiba Y; Sano H; Iwanaga T; Tohda Y
Eur J Pharmacol; 2020 Oct; 885():173508. PubMed ID: 32858049
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis.
Hunninghake GW; Gadek JE; Lawley TJ; Crystal RG
J Clin Invest; 1981 Jul; 68(1):259-69. PubMed ID: 7251862
[TBL] [Abstract][Full Text] [Related]
34. Ubiquitin carboxyl-terminal hydrolase-L5 promotes TGFβ-1 signaling by de-ubiquitinating and stabilizing Smad2/Smad3 in pulmonary fibrosis.
Nan L; Jacko AM; Tan J; Wang D; Zhao J; Kass DJ; Ma H; Zhao Y
Sci Rep; 2016 Sep; 6():33116. PubMed ID: 27604640
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast.
Gharaee-Kermani M; Hu B; Phan SH; Gyetko MR
Curr Med Chem; 2009; 16(11):1400-17. PubMed ID: 19355895
[TBL] [Abstract][Full Text] [Related]
36. NHLRC2 expression is increased in idiopathic pulmonary fibrosis.
Kreus M; Lehtonen S; Hinttala R; Salonen J; Porvari K; Kaarteenaho R
Respir Res; 2022 Aug; 23(1):206. PubMed ID: 35964085
[TBL] [Abstract][Full Text] [Related]
37. Integrated plasma proteomics and lung transcriptomics reveal novel biomarkers in idiopathic pulmonary fibrosis.
Sivakumar P; Ammar R; Thompson JR; Luo Y; Streltsov D; Porteous M; McCoubrey C; Cantu E; Beers MF; Jarai G; Christie JD
Respir Res; 2021 Oct; 22(1):273. PubMed ID: 34689792
[TBL] [Abstract][Full Text] [Related]
38. Identification of Pro-Fibrotic Macrophage Populations by Single-Cell Transcriptomic Analysis in West Highland White Terriers Affected With Canine Idiopathic Pulmonary Fibrosis.
Fastrès A; Pirottin D; Fievez L; Tutunaru AC; Bolen G; Merveille AC; Marichal T; Desmet CJ; Bureau F; Clercx C
Front Immunol; 2020; 11():611749. PubMed ID: 33384697
[TBL] [Abstract][Full Text] [Related]
39. Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis.
Morse C; Tabib T; Sembrat J; Buschur KL; Bittar HT; Valenzi E; Jiang Y; Kass DJ; Gibson K; Chen W; Mora A; Benos PV; Rojas M; Lafyatis R
Eur Respir J; 2019 Aug; 54(2):. PubMed ID: 31221805
[TBL] [Abstract][Full Text] [Related]
40. Investigating the role of platelets and platelet-derived transforming growth factor-β in idiopathic pulmonary fibrosis.
Chong DLW; Mikolasch TA; Sahota J; Rebeyrol C; Garthwaite HS; Booth HL; Heightman M; Denneny EK; José RJ; Khawaja AA; Duckworth A; Labelle M; Scotton CJ; Porter JC
Am J Physiol Lung Cell Mol Physiol; 2023 Oct; 325(4):L487-L499. PubMed ID: 37643008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
